New book edited by Martha Starr examines ethical, social, political, and cultural factors of financial …
- University Life
PhD, Economics, Boston University
BA, with First Class Honours, Mc Gill University
Service to the profession
"Economic approaches to estimating benefits of regulations affecting addictive goods" (with David Cutler, Amber Jessup, and Donald Kenkel), American Journal of Preventive Medicine, Vol. 50, no. 5 (supp. 1), pp. S20-S26 (May 2016).
“Do ‘Reverse Payment’ Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?” (with Thomas G. McGuire and Keith Drake), International Journal of the Business of Economics. Vol. 2, No. 2, 2015
“Decomposing growth in healthcare spending, 1980-2006: Prices, quantities, demographics and diseases” (with Ana Aizcorbe and Laura Dominiak), Health Affairs, Vol. 33, No. 5 (May 2014), pp. 823-831.
“Using differences-in-differences to estimate damages in healthcare antitrust: A case study of Marshfield Clinic” (with Forrest McCluer), International Journal of the Business of Economics, Vol. 30, No. 3 (Nov. 2013), pp. 447-469.
Consumption, saving, wealth, inequality, household economic behavior
Health economics, healthcare spending, health insurance, pharmaceuticals, antitrust
Macroeconomics, business cycles, recession, Federal Reserve
Prof. Starr's REPEC Page: http://ideas.repec.org/e/pst100.html